Exercise News and Research

Latest Exercise News and Research

Vertex Pharmaceuticals reports underwriters purchase additional stock at 38.50 per share

Vertex Pharmaceuticals Incorporated today announced that the underwriters of its public offering have exercised in full their option to purchase an additional 1,500,000 shares of common stock at the public offering price of $38.50 per share.

5 Dec 2009

Humana introduces senior-friendly dance pad video game at Kissimmee Guidance Center

What: Humana (http://www.humana.com), Florida's largest Medicare health benefits provider, is introducing Dancetown (http://humanagames.com), a senior-friendly dance pad video game at its Kissimmee Guidance Center on Tues., Dec. 8 at 1 p.m.

5 Dec 2009

Club Red Clinic offers preventive care for women with cardiovascular risk factors

When the University of Virginia Health System's new Club Red Clinic was on the drawing board, its organizers envisioned creating an innovative, cost-effective model for healthcare delivery. In a bold move, they decided to meld two timely healthcare concepts - prevention and shared medical appointments (SMAs) - into a unique clinical offering that has garnered overwhelmingly positive feedback from patients.

5 Dec 2009

FDA approves Santarus’ NDA for immediate-release prescription tablet product

Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s New Drug Application (NDA) for immediate-release omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40 mg and 20 mg dosage strengths of omeprazole.

5 Dec 2009

MedClean Technologies and Socius Capital Group enter into preferred stock purchase agreement

MedClean Technologies, Inc. today announced the Company has entered into a preferred stock purchase agreement with Socius Capital Group, LLC, a Delaware limited liability company, doing business as Socius Life Sciences Capital Group, LLC. Pursuant to the Purchase Agreement, MedClean will receive up to $7.5 million in capital.

5 Dec 2009

IntelGenx Technologies grants options to acquire 125,000 common shares

IntelGenx Technologies Corp. ("IntelGenx") (TSX VENTURE:IGX)(OTCBB:IGXT) announced today that the Company's board of directors granted options to acquire 125,000 common shares effective November 24, 2009. All options were granted under the 2006 Stock Option Plan with an exercise price of C$0.65 and expire in five years.

5 Dec 2009

Amorfix Life Sciences extends private placement warrants

Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, announced today it will not accelerate the expiry of the private placement warrants that were issued on April 29, 2009 with a $1.00 exercise price.

4 Dec 2009

Detroit Science Center launches "Diabetes: A Deeper Look" traveling exhibit

In the United States, a person is diagnosed with diabetes every 21 seconds. On December 5, 2009, the Detroit Science Center will debut its newest exhibit, Diabetes: A Deeper Look, to help answer questions that the public might have about diabetes, diabetes treatment and the role insulin plays in the body.

4 Dec 2009

Weight loss - an effective treatment for sleep apnoea in obese men

For obese men, a dramatic weight loss can be an effective way to improve moderate to severe sleep apnoea, scientists at the Swedish medical university Karolinska Institutet report. Those with severe sleep apnoea when the study began benefited most from weight loss.

4 Dec 2009

Climate change can cause major impact on global mental health

Leading mental health researchers are warning that some of the most important health consequences of climate change will be on mental health, yet this issue is unlikely to be given much attention at the UN climate change conference in Copenhagen next week.

4 Dec 2009

New research trial to study the impact of exercise on Parkinson's patients

Officials at the new Muhammad Ali Parkinson Center at Barrow Neurological Institute announced today the center's participation in a novel Parkinson's study aimed at determining the physical and neurological impact of simple exercise on Parkinson's patients.

4 Dec 2009

Global HIV reporting and monitoring system provides good indication of overall progress towards HIV goal

Although much work remains to be done, a United Nations global reporting system on HIV/AIDS has already yielded an "unequaled wealth of data" on progress toward meeting UN targets for responding to the global HIV epidemic.

3 Dec 2009

Body needs fasting periods to stay healthy

A body that is provided with food too often gets caught up in the maelstrom of a lack of exercise, obesity and ultimately diabetes. The trigger is a molecular switch that is controlled by insulin, a new study by scientists from ETH Zurich has revealed.

3 Dec 2009

New study suggests e-cigarettes can help alleviate nicotine cravings and improve general health

A groundbreaking new survey into the electronic cigarette, smokers' health and smoking cessation, carried out by NJOY retailers E Cigarette Direct and analysed by tobacco harm reduction scientists, has shown encouraging results.

3 Dec 2009

MaRS teams up with Baycrest to develop and market brain fitness products

One of the world's leading cognitive science institutes announced today it has created a new company with MaRS, Canada's premiere innovation centre, to develop and market brain fitness products to help adults extend their memory and cognitive abilities longer in the lifespan.

3 Dec 2009

European Phase III clinical trial of budesonide MMX completes patient enrollment

Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.

3 Dec 2009

Dementia patients with certain changes in their brain's white matter more likely to be apathetic

Dementia patients with a certain type of changes in their brain's white matter are more likely to be apathetic than those who do not have these changes, reveals a patient study carried out by the Sahlgrenska Academy and Sahlgrenska University Hospital.

3 Dec 2009

Exercise remains one of the most effective interventions for peripheral artery disease

Peripheral artery disease (PAD) affects 5 million individuals in the U.S. and is the leading cause of limb amputations. Doctors have long considered exercise to be the single best therapy for PAD, and now a new study helps explain why. Led by researchers at Beth Israel Deaconess Medical Center and published in this week's Online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), the findings demonstrate that a protein called PGC-1alpha plays a key role in the process.

3 Dec 2009

Sorin Group includes the first patient in its Clepsydra clinical trial

Sorin Group announced today the first inclusion of a patient in the Clepsydra clinical trial. The study will investigate the sensitivity to changes in heart failure status of PhD™, a unique diagnostic feature using the dual sensor technology of minute ventilation and accelerometer to monitor patient’s breathing and activity levels every day.

2 Dec 2009

Cancer Prevention Research Conference highlights new research on cancer

The American Association for Cancer Research Frontiers in Cancer Prevention Research Conference will focus on the latest biological, medical and social research behind cancer prevention.

2 Dec 2009

Exercise News and Research

Latest Exercise News and Research

Vertex Pharmaceuticals reports underwriters purchase additional stock at 38.50 per share

Humana introduces senior-friendly dance pad video game at Kissimmee Guidance Center

Club Red Clinic offers preventive care for women with cardiovascular risk factors

FDA approves Santarus’ NDA for immediate-release prescription tablet product

MedClean Technologies and Socius Capital Group enter into preferred stock purchase agreement

IntelGenx Technologies grants options to acquire 125,000 common shares

Amorfix Life Sciences extends private placement warrants

Detroit Science Center launches "Diabetes: A Deeper Look" traveling exhibit

Weight loss - an effective treatment for sleep apnoea in obese men

Climate change can cause major impact on global mental health

New research trial to study the impact of exercise on Parkinson's patients

Global HIV reporting and monitoring system provides good indication of overall progress towards HIV goal

Body needs fasting periods to stay healthy

New study suggests e-cigarettes can help alleviate nicotine cravings and improve general health

MaRS teams up with Baycrest to develop and market brain fitness products

European Phase III clinical trial of budesonide MMX completes patient enrollment

Dementia patients with certain changes in their brain's white matter more likely to be apathetic

Exercise remains one of the most effective interventions for peripheral artery disease

Sorin Group includes the first patient in its Clepsydra clinical trial

Cancer Prevention Research Conference highlights new research on cancer

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Exercise News and Research

Latest Exercise News and Research

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in